NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma

Bibliographic Details
Title: NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma
Authors: Soncini, Debora 1, Becherini, Pamela 2, Ladisa, Francesco 2, 3, Ravera, Silvia 1, 4, Chedere, Adithya 5, Gelli, Elisa 6, Giorgetti, Giulia 2, 3, Martinuzzi, Claudia 1, Piacente, Francesco 4, Mastracci, Luca 1, 7, Veneziano, Claudia 8, Santamaria, Gianluca 8, 9, Monacelli, Fiammetta 10, Ghanem, Moustafa S. 10, Cagnetta, Antonia 1, Guolo, Fabio 1, 2, Garibotto, Matteo 2, Aquino, Sara 11, Passalaqua, Mario 4, Bruzzone, Santina 1, 4, Bellotti, Axel 12, Duchosal, Michel A. 12, Nahimana, Aimable 12, Angelucci, Emanuele 11, Nagasuma, Chandra 5, Nencioni, Alessio 1, 10, Lemoli, Roberto Massimo 1, 2, Cea, Michele 1, 2, ∗
Source: In Blood Advances 11 March 2025 9(5):1024-1039
Database: ScienceDirect
More Details
ISSN:24739529
DOI:10.1182/bloodadvances.2024013425
Published in:Blood Advances
Language:English